William Blair Weighs in on Stericycle, Inc.’s Q3 2017 Earnings (SRCL)
Stericycle, Inc. (NASDAQ:SRCL) – Research analysts at William Blair lowered their Q3 2017 EPS estimates for Stericycle in a research report issued to clients and investors on Thursday. William Blair analyst R. Daniels now forecasts that the business services provider will post earnings per share of $1.14 for the quarter, down from their previous estimate of $1.17. William Blair also issued estimates for Stericycle’s Q4 2017 earnings at $1.23 EPS, FY2017 earnings at $4.61 EPS and FY2018 earnings at $4.84 EPS.
SRCL has been the subject of several other research reports. BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a report on Monday, July 24th. Jefferies Group LLC set a $108.00 price target on Stericycle and gave the stock a “buy” rating in a report on Thursday. Robert W. Baird downgraded Stericycle from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $74.00 to $73.00 in a report on Monday, May 15th. Deutsche Bank AG lowered their price target on Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a report on Monday, May 15th. Finally, BMO Capital Markets assumed coverage on Stericycle in a report on Thursday, June 29th. They issued a “market perform” rating and a $81.00 price target for the company. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $81.15.
COPYRIGHT VIOLATION WARNING: “William Blair Weighs in on Stericycle, Inc.’s Q3 2017 Earnings (SRCL)” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/08/07/william-blair-weighs-in-on-stericycle-inc-s-q3-2017-earnings-srcl.html.
Stericycle (SRCL) opened at 78.45 on Monday. The firm has a 50-day moving average price of $76.84 and a 200-day moving average price of $80.67. The stock has a market cap of $6.69 billion, a price-to-earnings ratio of 40.88 and a beta of 0.13. Stericycle has a 12 month low of $71.52 and a 12 month high of $90.45.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. Stericycle had a positive return on equity of 14.23% and a negative net margin of 0.07%. The business had revenue of $917.70 million during the quarter, compared to analyst estimates of $902.81 million. During the same quarter in the previous year, the firm earned $1.18 EPS. Stericycle’s revenue was up 2.9% on a year-over-year basis.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Kernodle & Katon Asset Management Group LLC purchased a new position in shares of Stericycle during the first quarter valued at about $100,000. Heritage Trust Co purchased a new position in shares of Stericycle during the first quarter valued at about $124,000. Pacer Advisors Inc. boosted its position in shares of Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares during the last quarter. Invictus RG purchased a new position in shares of Stericycle during the first quarter valued at about $145,000. Finally, Morgan Dempsey Capital Management LLC boosted its position in shares of Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares during the last quarter. Hedge funds and other institutional investors own 95.12% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.